Guangdong Academy of Medical Sciences - Academic Profile

Publications

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok , Yi‐Long Wu , Iveta Kudaba +97 more

2019 The Lancet 3175 citations

Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer

Yi‐Long Wu , Masahiro Tsuboi , Jie He +21 more

In patients with stage IB to IIIA <i>EGFR</i> mutation-positive NSCLC, disease-free survival was significantly longer among those who received osimertinib than among those who r...

2020 New England Journal of Medicine 1609 citations

Ideal cardiovascular health metrics and its association with 20-year cardiovascular morbidity and mortality in a Chinese population

Long Zhou , Liancheng Zhao , Yong Wu +8 more

Background The American Heart Association (AHA) developed a simplified assessment tool based on seven ideal cardiovascular health (CVH) metrics, but the relationship between the...

2018 Journal of Epidemiology & Community H... 61 citations

Affiliated Researchers

Institution Info

Type: healthcare
Country: CN
Publications: 3
Citations: 4,845

External Links

Identifiers

ROR: https://ror.org/0432p8t34